Author

Verónica Calvo

HiberCell, Inc. (United States)ORCID 0009-0004-3973-3006Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cell Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Organism:mouse· 1 Assay:proteomics· 1

Frequent Co-Authors

Advaita Chakraborty· 1 shared Bobbie‐Jo Webb‐RobertsoniD· 1 shared Cara M. AndersoniD· 1 shared Charanya MuralidharaniD· 1 shared David SurguladzeiD· 1 shared Decio Laks EizirikiD· 1 shared Emily Kristen SimsiD· 1 shared Ernesto Satoshi NakayasuiD· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCell Biology

Advaita Chakraborty

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cell BiologyJournal of Clinical InvestigationPeer-reviewedJun 18, 2024

Inhibition of the Eukaryotic Initiation Factor-2-α Kinase PERK Decreases Risk of Autoimmune Diabetes in Mice

Charanya Muralidharan, Fei Huang, Jacob R. Enriquez…·Raghavendra G. Mirmira

This study shows that inhibiting PERK reduces autoimmune diabetes risk in mice by decreasing β cell immunogenicity and improving islet function.

22 citationstop 4%

𝕏 PostBluesky